Action EMH EMERALD HEALTH THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Emerald Health Therapeutics, Inc. Toronto S.E.

Actions

EMH

CA29102R1064

Cours en clôture Toronto S.E.
Autres places de cotation
 00:00:00 05/05/2021 		Varia. 5j. Varia. 1 janv.
0,235 CAD -4,08 % Graphique intraday de Emerald Health Therapeutics, Inc. -.--% +27,50 %
2023 C3 Souvenir Holding, Inc. a conclu l'acquisition de Verdelite Sciences, Inc. auprès d'Emerald Health Therapeutics, Inc. CI
2022 Skye Bioscience, Inc. (OTCPK:SKYE) a complété l'acquisition d'Emerald Health Therapeutics, Inc. (CNSX:EMH) auprès d'Emerald Health Sciences Inc. et autres. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.
C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.
CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.
IIROC Trading Halt - EMH
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Skye Bioscience Reports that CSE-listed Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement
Certain Emerald Health Shareholders Oppose Proposed Merger with Skye Biosciences
Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Emerald Health Therapeutics : 2021 Q4
Emerald Health Therapeutics : 2021 - Audited Financial Statements
Emerald Health Therapeutics, Inc. - Reports 2021 Year-end Results and Corporate Update
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Emerald Health Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Skye Bioscience, Inc. entered into term sheet to acquire Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others for CAD 24.4 million.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action EMH
  4. Action EMH
  5. Actualités Emerald Health Therapeutics, Inc.
  6. Autres langues